Introductionĭiabetes mellitus (DM) is a chronic, multifactorial set of metabolic diseases arising from deficiencies in insulin synthesis, insulin potency, or both which often manifests as severe hyperglycaemia.
While studies are underway to demystify the yet to be identified compounds in the extract, the data presented have lent scientific credence to the acclaimed in vivo antidiabetic potential of the extract and suggested it as a viable source of oral hypoglycaemic agent. These observations are suggestive of involvement of these compounds as probable ligands contributing to antidiabetic potential of the extract. Of the identified compounds, dianoside G (−12.4, −12.5 kcal/mol) and trilobine (−10.0, −10.0 kcal/mol) had significant interactions with α-amylase and α-glucosidase, respectively, while magnoflorine and asiatic acid also interacted keenly with both enzymes, with quercetin 3-O-glucuronide and strictosidine showing better affinity towards α-glucosidase. The extract competitively and uncompetitively inhibited α-amylase and α-glucosidase, respectively. The extract had concentration-dependent inhibitory effect on the study enzymes, and the inhibition compared well with that of standard drug (acarbose) with respective IC 50 values of 0.67 mg/mL ( α-amylase) and 0.57 mg/mL ( α-glucosidase) compared with that of the extract (0.63 and 0.54 mg/mL). ringens on α-amylase and α-glucosidase in vitro and in silico, while its constituents were characterized using liquid chromatography-mass spectrometric technique. The current study evaluated the inhibitory mechanism(s) of root extract of A. Aristolochia ringens is among the scientifically implicated botanicals effective in the management of several degenerative diseases including DM.
Diabetes mellitus (DM) has become a global scourge, and there is a continuous search for novel compounds as viable alternatives to synthetic drugs which are often accompanied by severe adverse effects.